0.00Open0.00Pre Close0 Volume0 Open Interest17.50Strike Price0.00Turnover7408.11%IV143.06%PremiumMay 17, 2024Expiry Date10.30Intrinsic Value100Multiplier-7DDays to Expiry0.00Time Value100Contract SizeAmericanOptions Type-0.8629Delta0.0482Gamma--Leverage Ratio-20.9897Theta0.0000Rho0.00Eff Leverage0.0001Vega
Grifols Stock Discussion
Grifols (GRF.MC) said Monday that the sale of its 20% stake in blood products company Shanghai RAAS to Chinese home appliance company Haier Group is expected to be completed by June.
The Spanish pharmaceutical company said both the buyer and seller secured the necessary domestic and overseas government approvals for the deal. It noted that the transaction still requires a compliance confirmation from the Shenzhen Stock Exchange.
The Spanish pharmaceutical group said Tuesday the note offering is contingent upon the fulfillment of customary closing conditions.
MT Newswires· 2 mins ago
Grifols (GRF.MC) said Thursday its automated nucleic acid test secured CE marking, representing the first for the medical device.
Procleix ArboPlex Assay is designed to screen blood donors to detect arboviruses diseases such as chikungunya, dengue, West Nile, and Zika viruses.
The Spanish pharmaceutical group said the test will soon be available worldwide to those accepting the CE...
Treasury yields jumped on Thursday, and indexes fell after data showed a bigger-than-expected jump in producer prices during February, keeping inflation worries alive. The market reversed from larger declines shortly before closing.
With the preliminary closing numbers, the $S&P 500 Index(.SPX.US)$ fell 0.29%, the $Dow Jones Industrial Average(.DJI.US)$ fell 0.35%, the $Nasdaq Composite Index(.IXIC.US)$...
No comment yet